{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:17:58Z","timestamp":1761675478560,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2006,7,10]]},"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1783\/147118907780254123","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T18:50:28Z","timestamp":1174503028000},"page":"125-126","source":"Crossref","is-referenced-by-count":10,"title":["Ectopic pregnancy with Implanon<sup>\u00ae<\/sup>"],"prefix":"10.1136","volume":"33","author":[{"given":"Patricia M N","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morven D","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"ref_1","article-title":"Implanon Implant for Subdermal Use. Organon EU SmPC RA 0450 EU S7","author":"[2 July 2006].","year":"7.0).","unstructured":"Implanon Implant for Subdermal Use. Organon EU SmPC RA 0450 EU S7 (REF 7.0). http:\/\/hcp.implanon.com\/Images\/ SMPCImplanonV7_tcm624-170329.pdf [Accessed 2 July 2006]."},{"issue":"6","key":"ref_2","first-page":"306","article-title":"The pharmacodynamics and efficacy of Implanon. An overview of the data","volume":"58","author":"Croxatto, H.B.; Makarainen, L.","year":"1998","unstructured":"Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 1998; 58(6 Suppl.): 91S\u201397S. 3 Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005; 71: 306\u2013308.","journal-title":"Contraception; Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia"},{"key":"ref_3","first-page":"986","article-title":"le reseau des centres regionaux de pharmacovigilance. Insertion problems, removal problems, and contraception failures with Implanon","volume":"33","author":"Bensouda-Grimaldi, L.; Jonville-Bera, A.P.; Beau-Salinas, F.; Llabres, S.; Autret-Leca, E.","year":"2005","unstructured":"Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E; le reseau des centres regionaux de pharmacovigilance. Insertion problems, removal problems, and contraception failures with Implanon [in French]. Gynecol Obstet Fertil 2005; 33: 986\u2013990.","journal-title":"Gynecol Obstet Fertil"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2125.1992.tb04134.x","article-title":"The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes","volume":"34","author":"Crewe, H.K.; Lennard, M.S.; Tucker, G.T.; Woods, F.R.; Haddock, R.E.","year":"1992","unstructured":"Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 1992; 34: 262\u2013265.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1093\/humrep\/13.12.3371","article-title":"The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study","volume":"13","author":"Sivin, I.; Campodonico, I.; Kiriwat, O.; Holma, P.; Diaz, S.; Wan, L.","year":"1998","unstructured":"Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, et al. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. Hum Reprod 1998; 13: 3371\u20133378.","journal-title":"Hum Reprod"},{"key":"ref_6","first-page":"608","article-title":"Extrauterine pregnancy with etonogestrel contraceptive implant (Implanon): first case","volume":"34","author":"Mansour, M.; Louis-Sylvestre, C.; Paniel, B.J.","year":"2005","unstructured":"Mansour M, Louis-Sylvestre C, Paniel BJ. Extrauterine pregnancy with etonogestrel contraceptive implant (Implanon): first case [in French]. J Gynecol Obstet Biol Reprod (Paris) 2005; 34: 608\u2013609..","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref_7","article-title":"Emergencies in Obstetrics and Gynaecology","author":"Arulkumaran, S.","year":"2006","unstructured":"Emergencies in Obstetrics and Gynaecology. S Arulkumaran (ed.). Oxford, UK: Oxford University Press, 2006. ISBN: 978-0-19-856730-1. Price: \u00a315.95. Pages: 290 (paperback)"},{"key":"ref_8","article-title":"MRCOG Specialist Registrar in Obstetrics and Gynaecology, Londonderry, Northern Ireland Family Planning Masterclass: Evidence-based Answers to 1000 Questions","volume-title":"G Penney, S Brechin, A Glasier","author":"Reviewed by Munawar Hussain, F.C.P.S.","year":"2006","unstructured":"Reviewed by Munawar Hussain, FCPS, MRCOG Specialist Registrar in Obstetrics and Gynaecology, Londonderry, Northern Ireland Family Planning Masterclass: Evidence-based Answers to 1000 Questions. G Penney, S Brechin, A Glasier (eds). London, UK: RCOG Press, 2006. ISBN: 1-904752-33-0. Price: \u00a348.00 (limited special offer price for RCOG\/FFPRHC members \u00a336.00). Pages: 594 (paperback)"},{"key":"ref_9","article-title":"responses have been updated and there is some inconsistent information. For example, we are told that follicle-stimulating hormone (FSH) is inaccurate for assessing menopause status in women on combined oral contraceptives (p. 278) and can only be useful if the woman discontinues sex steroid hormones. Fortunately, the response to the subsequent question gives more practical guidance (i.e. that FSH levels greater than 25 mIU\/ml on Day 6 or 7 of the pill-free week in perimenopausal women suggests that contraception is no longer necessary). Another example is the advice on when an IUD can be inserted (p. 142). I\u2019ll stick with teaching the 2004 CEU advice1 \u201cup to 5 days after the earliest calculated time of ovulation in a regular cycle\u201d","author":"Not all","year":"cited","unstructured":"Not all responses have been updated and there is some inconsistent information. For example, we are told that follicle-stimulating hormone (FSH) is inaccurate for assessing menopause status in women on combined oral contraceptives (p. 278) and can only be useful if the woman discontinues sex steroid hormones. Fortunately, the response to the subsequent question gives more practical guidance (i.e. that FSH levels greater than 25 mIU\/ml on Day 6 or 7 of the pill-free week in perimenopausal women suggests that contraception is no longer necessary). Another example is the advice on when an IUD can be inserted (p. 142). I\u2019ll stick with teaching the 2004 CEU advice1 \u201cup to 5 days after the earliest calculated time of ovulation in a regular cycle\u201d rather than the cited WHO advice \u201cwithin the first 12 days after the start of menstrual bleeding\u201d. The former is by far the more practical guidance.","journal-title":"rather than the; WHO advice \u201cwithin the first 12 days after the start of menstrual bleeding\u201d. The former is by far the more practical guidance"},{"key":"ref_10","first-page":"29","article-title":"Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit","volume":"30","year":"2004","unstructured":"Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004; 30: 29\u201342.","journal-title":"The copper intrauterine device as long-term contraception; J Fam Plann Reprod Health Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1783\/147118902101196784","article-title":"Bleeding problems and progestogen-only contraception (FACT","volume":"28","author":"Porter, C.; Rees, M.C.P.","year":"2002","unstructured":"Porter C, Rees MCP. Bleeding problems and progestogen-only contraception (FACT Review). J Fam Plann Reprod Health Care 2002; 28: 178\u2013181.","journal-title":"Review). J Fam Plann Reprod Health Care"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118907780254123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:14:34Z","timestamp":1757099674000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118907780254123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,4,1]]},"published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1783\/147118907780254123"],"URL":"https:\/\/doi.org\/10.1783\/147118907780254123","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}